These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17679465)

  • 1. Beta-catenin and CD44 expression in keratoacanthoma and squamous cell carcinoma of the skin.
    Tataroglu C; Karabacak T; Apa DD
    Tumori; 2007; 93(3):284-9. PubMed ID: 17679465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratoacanthoma and squamous cell carcinoma of the skin: immunohistochemical localization of involucrin and keratin proteins.
    Smoller BR; Kwan TH; Said JW; Banks-Schlegel S
    J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):226-34. PubMed ID: 2419374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma.
    Phillips P; Helm KF
    J Cutan Pathol; 1993 Oct; 20(5):424-8. PubMed ID: 7507945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study.
    Soddu S; Di Felice E; Cabras S; Castellanos ME; Atzori L; Faa G; Pilloni L
    Eur J Histochem; 2013 Feb; 57(1):e6. PubMed ID: 23549465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
    Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
    Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas.
    Jensen P; Clausen OP; Bryne M
    J Cutan Pathol; 1999 Apr; 26(4):183-9. PubMed ID: 10335895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.
    Melendez ND; Smoller BR; Morgan M
    Mod Pathol; 2003 Jan; 16(1):8-13. PubMed ID: 12527707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
    Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
    Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.